Pharma
HKU’s COSA Osteoporosis Community Screening Program Identifies Over 1,000 High-Risk Seniors from 5,000 Screenings
HONG KONG SAR 6 October 2024 – The Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, has...
Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia
New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it...
Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic
Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak...
LiveSpo Pharma Emerges as Vietnam’s Pioneer at Vitafoods Europe 2024
Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care HANOI, VIETNAM 17 May 2024 – LiveSpo Pharma...
Triastek’s 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application
Triastek‘s 3D printed gastric retention product T22 received IND clearance from the FDA, becoming the world‘s first 3D printed gastric retention product. Currently,...
Watsons Singapore Launches Tru Niagen® Immune, a Groundbreaking Formula for Age Transformation and Immunity Boost
SINGAPORE 24 January 2024 – Tru Niagen® Immune, the latest innovation from the creators of the esteemed Tru Niagen brand, is set to...
Livespo Navax – World’s first spore probiotics in nasal spray form triumphs in ongoing clinical trials tackling influenza-related respiratory inflammation
HANOI, VIETNAM – 30 November 2023 – A recent publication in the Scientific Reports – Nature journal has once again highlighted the clinical...
Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
87% of respondents deemed mRNA a key modality for the future More than 60% vaccine makers surveyed plan revamp or new facilities for...
Vetter Strengthens Worldwide Commitment to Sustainable Business Practices
CDMO joins United Nations Global Compact Globally, Vetter is one of over 300 companies in the pharma and biotech industry that have signed...
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development Clinical development pipeline is essential to global business...